Novel polyethylenimine-derived nanoparticles for in vivo gene delivery

Expert Opinion on Drug Delivery

Volumn 10, Issue 2, 2013, Pages 215-228

  Patnaik, Soma ^a   Gupta, Kailash C ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

Author keywords

Cancer therapeutics; in vivo; Nonviral vector; Polyethylenimine; RNA interference

Indexed keywords

3,3' DITHIOBISPROPIONIMIDIC ACID DIMETHYL ESTER; ALPHA INTERFERON; ASIALOGLYCOPROTEIN RECEPTOR; BETA CYCLODEXTRIN; CHITOSAN; COIXAN POLYSACCHARIDE; COPOLYMER; DITHIOBIS(SUCCINIMIDYLPROPIONATE) ESTER; EPIDERMAL GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR; FLOXURIDINE; FOLIC ACID; GOLD NANOPARTICLE; LIPOSOME; MACROGOL; MICRORNA; NANOPARTICLE; NERVE GROWTH FACTOR; OLIGOPEPTIDE; POLYETHYLENEIMINE; POLYINOSINIC POLYCYTIDYLIC ACID; POLYMER; POLYSACCHARIDE; PROTEIN TYROSINE KINASE A; SMALL INTERFERING RNA; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; SURVIVIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VESICULAR STOMATITIS VIRUS MATRIX PROTEIN; VIRUS PROTEIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BLOOD BRAIN BARRIER; CANCER GENE THERAPY; CHEMICAL STRUCTURE; CROSS LINKING; CYTOTOXICITY; DRUG BIOAVAILABILITY; DRUG CONJUGATION; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG TARGETING; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; IN VIVO GENE TRANSFER; MOLECULAR WEIGHT; NONHUMAN; NONVIRAL GENE THERAPY; REVIEW; RNA INTERFERENCE; SYNTHESIS;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GENETIC VECTORS; HUMANS; MOLECULAR WEIGHT; NANOPARTICLES; POLYETHYLENEIMINE; POLYMERS; TRANSFECTION;

EID: 84872741585     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2013.744964     Document Type: Review

References (78)

1. Marschall P, Malik N, Larin Z. Transfer of YACs up to 2. 3 Mb intact into human cells with polyethylenimine. Gene Ther 1999;6:1634-7 (Pubitemid 29465523)
2. Campeau P, Chapdelaine P, Seigneurin-Venin S, et al. Transfection of large plasmids in primary human myoblasts. Gene Ther 2001;8:1387-94 (Pubitemid 32895669)
3. Boussif O, Lezoualc'h F, Zanta MA, et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 1995;92:7297-301
4. Baker A, Saltik M, Lehrmann H, et al. Polyethylenimine (PEI) is a simple, inexpensive and effective reagent for condensing and linking plasmid DNA to adenovirus for gene delivery. Gene Ther 1997;4:773-82 (Pubitemid 27380159)
5. Meunier-Durmort C, Grimal H, Sachs LM, et al. Adenovirus enhancement of polyethylenimine-mediated transfer of regulated genes in differentiated cells. Gene Ther 1997;4:808-14 (Pubitemid 27380163)
6. Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J Biomed Mater Res 1999;45:268-75 (Pubitemid 29165943)
7. Morimoto K, Nishikawa M, Kawakami S, et al. Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethyleneimine on hepatoma cells and mouse liver. Mol Ther 2003;7:254-61 (Pubitemid 36395361)
8. Wightman L, Kircheis R, Rossler V, et al. Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med 2001;3:362-72 (Pubitemid 33691776)
9. Goula D, Remy JS, Erbacher P, et al. Size, diffusibility and transfection performance of linear PEI/DNA complexes in the mouse central nervous system. Gene Ther 1998;5:712-17 (Pubitemid 28256824)
10. Merkel OM, Zheng M, Debus H, Kissel T. Pulmonary gene delivery using polymeric nonviral vectors. Bioconjug Chem 2012;23:3-20
11. Godbey WT, Barry MA, Saggau P, et al. Poly(ethylenimine)-mediated transfection: a new paradigm for gene delivery. J Biomed Mater Res 2000;51:321-8 (Pubitemid 30452134)
12. Fischer D, Bieber T, Li Y, et al. A novel non-viral vector for DNA delivery based on low molecular weight, branched polyethylenimine: effect of molecular weight on transfection efficiency and cytotoxicity. Pharm Res 1999;16:1273-9 (Pubitemid 29393618)
13. Pathak A, Kumar P, Chuttani K, et al. Gene expression, biodistribution and pharmacoscintigraphic evaluation of chondroitin sulfate-PEI nanoconstructs mediated tumor gene therapy. ACS Nano 2009;3:1493-505
14. Pathak A, Swami A, Patnaik S, et al. Efficient tumor targeting by polysaccharide decked polyethylenimine based Nanocomposites. J Biomed Nanotechnol 2009;5:264-77
15. Goyal R, Tripathi SK, Tyagi S, et al. Gellan gum blended PEI nanocomposites as gene delivery agents: evidences from in vitro and in vivo studies. Eur J Pharm Biopharm 2011;79:3-14
16. Tripathi SK, Goyal R, Gupta KC. Surface modification of crosslinked dextran nanoparticles influences transfection efficiency of dextran- polyethylenimine nanocomposites. Soft Matter 2011;7:11360-71
17. Tripathi SK, Goyal R, Ansari KM, et al. Polyglutamic acid-based nanocomposites as efficient non-viral gene carriers in vitro and in vivo. Eur J Pharm Biopharm 2011;79:473-84
18. Patnaik S, Tripathi SK, Goyal R, et al. Polyethylenimine- polyethyleneglycol-bis (aminoethylphosphate) nanoparticles mediated efficient DNA and siRNA transfection in mammalian cells. Soft Matter 2011;7:6103-12
19. Patnaik S, Goyal R, Tripathi SK, et al. Engineered PEI-piperazinyl nanoparticles as efficient gene delivery vectors: evidence from both in vitro and in vivo studies. RSC Adv 2012;2:4335-42
20. Goyal R, Tripathi SK, Tyagi S, et al. Linear PEI nanoparticles: Efficient pDNA/siRNA carriers in vitro and in vivo. Nanomedicine 2012;8:167-75
21. Goyal R, Bansal R, Tyagi S, et al. 1, 4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo. Mol Biosyst 2011;7:2055-65
22. Park Y, Kwok KY, Boukarim C, Rice KG. Synthesis of sulfhydryl cross-linking poly(ethyleneglycol)-peptides and glycopeptides as carriers for gene delivery. Bioconjug Chem 2002;13:232-9 (Pubitemid 34267934)
23. Tang GP, Guo HY, Alexis F, et al. Low molecular weight polyethylenimines linked by beta-cyclodextrin for gene transfer into the nervous system. J Gene Med 2006;8:736-44
24. Kim YH, Park JH, Lee M, et al. Polyethylenimine with acid-labile linkages as a biodegradable gene carrier. J Control Release 2005;103:209-19 (Pubitemid 40248573)
25. Kircheis R, Schüller S, Brunner S, et al. Polycation-based DNA complexes for tumor-targeted gene delivery in vivo. J Gene Med 1999;1:111-20 (Pubitemid 129631068)
26. Lu X, Ping Y, Xu FJ, et al. Bifunctional conjugates comprising b-cyclodextrin, polyethylenimine, and 5-fluoro-2¢-deoxyuridine for drug delivery and gene transfer. Bioconjug Chem 2010;21:1855-63
27. Tripathi SK, Goyal R, Kashyap MP, et al. Depolymerized chitosans functionalized with bPEI as carriers of nucleic acids and tuftsin-tethered conjugate for macrophage targeting. Biomaterials 2012;33:4204-19
28. Li D, Ping Y, Xu F, et al. Construction of a star-shaped copolymer as a vector for FGF receptor-mediated gene delivery in vitro and in vivo. Biomacromolecules 2010;11:2221-9
29. Huang H, Yu H, Tang G, et al. Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gammacyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. Biomaterials 2010;31:1830-8
30. Zeng J, Wang X, Wang S. Self-assembled ternary complexes of plasmid DNA, low molecular weight polyethylenimine and targeting peptide for nonviral gene delivery into neurons. Biomaterials 2007;28:1443-51 (Pubitemid 46001462)
31. Zhang L, Gao X, Men K, et al. Gene therapy for C-26 colon cancer using heparin-polyethyleneimine nanoparticle-mediated survivin T34A. Int J Nanomed 2011;6:2419-27
32. Gou M, Men K, Zhang J, et al. Efficient inhibition of C-26 colon carcinoma by VSVMP gene delivered by biodegradable cationic nanogel derived from polyethyleneimine. ACS Nano 2010;4:5573-84
33. Jiang Q, Shi P, Li C, et al. (Coixan polysaccharide)-graft- polyethylenimine folate for tumor-targeted gene delivery. Macromol Biosci 2011;11:435-44
34. Sharma A, Tandon A, Tovey JC, et al. Polyethylenimine-conjugated gold nanoparticles: gene transfer potential and low toxicity in the cornea. Nanomedicine 2011;7:505-13
35. Ma K, Hu M, Xie M, et al. Investigation of polyethylenimine-grafted- triamcinolone acetonide as nucleus-targeting gene delivery systems. J Gene Med 2010;12:669-80
36. Ma K, Shen H, Shen S, et al. Development of a successive targeting liposome with multi-ligand for efficient targeting gene delivery. J Gene Med 2011;13:290-301
37. Hyun H, Lee J, Hwang do W, et al. Combinational therapy of ischemic brain stroke by delivery of heme oxygenase-1 gene and dexamethasone. Biomaterials 2011;32:306-15
38. Son S, Hwang do W, Singha K, et al. RVG peptide tethered bioreducible polyethylenimine for gene delivery to brain. J Control Release 2011;155:18-25
39. Kumar P, Wu H, McBride JL, et al. Transvascular delivery of small interfering RNA to the central nervous system. Nature 2007;448:39-43 (Pubitemid 47037001)
40. Yang YP, Chien Y, Chiou GY, et al. Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI. Biomaterials 2012;33:1462-76
41. Ibrahim AF, Weirauch U, Thomas M, et al. MicroRNA replacement therapy for miR-145 and miR-33a is efficacious in a model of colon carcinoma. Cancer Res 2011;71:5214-24
42. Hwang DW, Son S, Jang J, et al. A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA. Biomaterials 2011;32:4968-75
43. Rapoport SI. Advances in osmotic opening of the blood-brain barrier to enhance CNS chemotherapy. Expert Opin Investig Drugs 2001;10:1809-18 (Pubitemid 32982807)
44. Kim JS, Yoon TJ, Yu KN, et al. Toxicity and tissue distribution of magnetic nanoparticles in mice. Toxicol Sci 2006;89:338-47 (Pubitemid 43013783)
45. Kaestner P, Aigner A, Bastians H. Therapeutic targeting of the mitotic spindle checkpoint through nanoparticle-mediated siRNA delivery inhibits tumor growth in vivo. Cancer Lett 2011;304:128-36
46. Pi Y, Zhang X, Shi J, et al. Targeted delivery of non-viral vectors to cartilage in vivo using a chondrocyte-homing peptide identified by phage display. Biomaterials 2011;32:6324-32
47. Shir A, Ogris M, Roedl W, et al. EGFR-homing dsRNA activates cancer targeted immune response and eliminates disseminated EGFR over-expressing tumors in mice. Clin Cancer Res 2011;17:1033-43
48. Yeh CC, Hsieh HL, Lee J, et al. Polyethylenimine-mediated PUMA gene delivery to orthotopic oral cancer: suppression of tumor growth through apoptosis induction in situ and prolonged survival. Head Neck 2011;33:878-85
49. Xu Z, Shen G, Xia X, et al. Comparisons of three polyethyleneimine- derived nanoparticles as a gene therapy delivery system for renal cell carcinoma. J Transl Med 2011;9:46-55
50. Zhang C, Gao S, Jiang W, et al. Targeted minicircle DNA delivery using folate-poly(ethylene glycol)-polyethylenimine as non-viral carrier. Biomaterials 2010;31:6075-86
51. Kwon EJ, Lasiene J, Jacobson BE, et al. Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone. Biomaterials 2010;31:2417-24
52. Kleemann E, Neu M, Jekel N, et al. Nano-carriers for DNA delivery to the lung based upon a TAT-derived peptide covalently coupled to PEG-PEI. J Control Release 2005;109:299-316 (Pubitemid 41737272)
53. Chen J, Gao X, Hu K, et al. Galactosepoly( ethylene glycol)- polyethylenimine for improved lung gene transfer. Biochem Biophys Res Commun 2008;375:378-83
54. Kim HW, Park IK, Cho CS, et al. Aerosol delivery of glucosylated polyethylenimine/phosphatase and tensin homologue deleted on chromosome 10 complex suppresses Akt downstream pathways in the lung of K-ras null mice. Cancer Res 2004;64:7971-6
55. Pfeifer C, Hasenpusch G, Uezguen S, et al. Dry powder aerosols of polyethylenimine (PEI)-based gene vectors mediate efficient gene delivery to the lung. J Control Release 2011;154:69-76
56. Zhang J, Duan Y, Wei D, et al. Co-electrospun fibrous scaffold-adsorbed DNA for substrate-mediated gene delivery. J Biomed Mater Res A 2011;96:212-20
57. Wang C, Ravi S, Martinez GV, et al. Dual-purpose magnetic micelles for MRI and gene delivery. J Control Release 2012;163:82-92
58. Yang J, Lee ES, Noh MY, et al. Ambidextrous magnetic nanovectors for synchronous gene transfection and labeling of human MSCs. Biomaterials 2011;32:6174-82
59. Zhan C, Meng Q, Li Q, et al. Cyclic RGD-polyethylene glycolpolyethylenimine for intracranial glioblastoma-targeted gene delivery. Chem Asian J 2012;7:91-6
60. Pham W, Zhao BQ, Lo EH, et al. Crossing the blood-brain barrier: a potential application of myristoylated polyarginine for in vivo neuroimaging. Neuroimage 2005;28:287-92 (Pubitemid 41393908)
61. Meng Q, Yu M, Gu B, et al. Myristic acid-conjugated polyethylenimine for brain-targeting delivery: in vivo and ex vivo imaging evaluation. J Drug Target 2010;18:438-46
62. Li J, Gu B, Meng Q, et al. The use of myristic acid as a ligand of polyethylenimine/DNA nanoparticles for targeted gene therapy of glioblastoma. Nanotechnology 2011;22:435101
63. Alshamsan A, Hamdy S, Samuel J, et al. The induction of tumor apoptosis in B16 melanoma following STAT3 siRNA delivery with a lipid-substituted polyethylenimine. Biomaterials 2010;31:1420-8
64. Jeong JH, Kim SH, Lee M, et al. Non-viral systemic delivery of Fas siRNA suppresses cyclophosphamide-induced diabetes in NOD mice. J Control Release 2010;143:88-94
65. Lu ZX, Liu LT, Qi XR. Development of small interfering RNA delivery system using PEI-PEG-APRPG polymer for antiangiogenic vascular endothelial growth factor tumor-targeted therapy. Int J Nanomed 2011;6:1661-73
66. Merkel OM, Beyerle A, Librizzi D, et al. Nonviral siRNA delivery to the lung: investigation of PEG-PEI polyplexes and their in vivo performance. Mol Pharm 2009;6:1246-60
67. Liu L, Liu H, Visner G, Fletcher BS. Sleeping Beauty-mediated eNOS gene therapy attenuates monocrotaline-induced pulmonary hypertension in rats. FASEB J 2006;20:2594-6
68. Belur LR, Frandsen JL, Dupuy AJ, et al. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system. Mol Ther 2003;8:501-7 (Pubitemid 37161472)
69. Belur LR, Podetz-Pedersen K, Frandsen J, McIvor RS. Lung-directed gene therapy in mice using the nonviral Sleeping Beauty transposon system. Nat Protoc 2007;2:3146-52
70. Liu H, Liu L, Fletcher BS, Visner GA. Sleeping Beauty-based gene therapy with indoleamine 2, 3-dioxygenase inhibits lung allograft fibrosis. FASEB J 2006;20:2384-6
71. Chen ZY, Liang K, Qiu RX. Targeted gene delivery in tumor xenografts by the combination of ultrasound-targeted microbubble destruction and polyethylenimine to inhibit survivin gene expression and induce apoptosis. J Exp Clin Cancer Res 2010;29:152-60
72. Chen ZY, Liang K, Qiu RX, Luo LP. Ultrasound-and liposome microbubble-mediated targeted gene transfer to cardiomyocytes in vivo accompanied by polyethylenimine. J Ultrasound Med 2011;30:1247-58
73. Sidi AA, Ohana P, Benjamin S, et al. Phase I/II marker lesion study of intravesical BC-819 DNA plasmid in H19 over expressing superficial bladder cancer refractory to bacillus Calmette-Guerin. J Urol 2008;180:2379-83
74. Bonnet ME, Erbacher P, Bolcato-Bellemin AL. Systemic delivery of DNA or siRNA mediated by linear polyethylenimine (L-PEI) does not induce an inflammatory response. Pharm Res 2008;25:2972-82
75. Hassani Z, Lemkine GF, Erbacher P, et al. Lipid-mediated siRNA delivery down-regulates exogenous gene expression in the mouse brain at picomolar levels. J Gene Med 2005;7:198-207 (Pubitemid 40348024)
76. Bolcato-Bellemin AL, Bonnet ME, Creusat G, et al. Sticky overhangs enhance siRNA-mediated gene silencing. Proc Natl Acad Sci USA 2007;104:16050-5 (Pubitemid 350099361)
77. Urban-Klein B, Werth S, Abuharbeid S, et al. RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther 2005;12:461-6 (Pubitemid 40394299)
78. Ge Q, Filip L, Bai A, et al. Inhibition of influenza virus production in virus-infected mice by RNA interference. Proc Natl Acad Sci USA 2004;101:8676-81 (Pubitemid 38745830)